Study of a new device for atrial fibrillation ablation
Part of Heart & circulation clinical trials.
This study looks at how often silent brain lesions happen after a new type of heart procedure for atrial fibrillation (an irregular heartbeat). The procedure uses a device called the Varipulse catheter to help fix the heart's rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have a procedure for atrial fibrillation using the Varipulse catheter
- You are 19 years of age or older
- You have not had a stroke or transient ischemic attack (TIA) in the past
- You have not had a previous procedure or surgery for atrial fibrillation
- You have not had a blood clot in the heart or an embolic event in the last 90 days
- You have not had heart surgery or a heart attack in the last 90 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat atrial fibrillation (a heart rhythm problem) using a special catheter that delivers quick electrical pulses to fix the heart's rhythm. The goal is to see if this method is safe and effective, which might offer an alternative to traditional treatments.
This study is for people with atrial fibrillation who are planning to have a catheter ablation procedure. It will look at how well the heart works after the procedure and how to prevent future events.
This trial is testing a new way to measure electrical signals in the heart during a procedure called pulmonary vein isolation, which treats atrial fibrillation (a type of irregular heartbeat). It is for people who are having this procedure for the first time and whose heart is in a normal rhythm at the time of treatment.
This trial tests a new balloon-based catheter procedure to treat persistent atrial fibrillation (a type of irregular heartbeat lasting at least a week). The procedure uses a special energy technique to stop abnormal electrical signals in your heart.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.